A Prospective, Single-Arm, Phase II Clinical Study of Neoadjuvant Therapy With Pucotenlimab, Lenvatinib, and Temozolomide for Resectable Head and Neck Mucosal Melanoma (PLT-NAT-HNMM-II)
PHASE2
This study aims to conduct a prospective clinical trial investigating the u...
Status
Not Yet Recruiting
Location
Shanghai Ninth People's Hospital affiliated to Shanghai Jiao Tong University School of Medicine
Clinical Efficacy of Pucotenlimab Combined With Lenvatinib and SOX Versus SOX Alone in Patients With HER2-Negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
EARLY_PHASE1
The purpose of this study is to evaluate the objective response rate (ORR) ...